Sei Investments CO Y M Abs Therapeutics, Inc. Transaction History

Sei Investments CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$6.55 - $17.42 $215,822 - $573,989	-32,950 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$15.51 - $29.31 $121,893 - $230,347	7,859 Added 31.32%	32,950 $534,000
Q3 2021 Nov 12, 2021	BUY	$27.47 - $37.31 $141,195 - $191,773	5,140 Added 25.76%	25,091 $716,000
Q2 2021 Aug 06, 2021	BUY	$25.45 - $37.64 $21,632 - $31,994	850 Added 4.45%	19,951 $674,000
Q1 2021 May 12, 2021	BUY	$29.16 - $51.96 $96,665 - $172,247	3,315 Added 21.0%	19,101 $578,000

Q4 2020 Feb 08, 2021	BUY	$37.86 - $54.26 $234,883 - $336,629	6,204 Added 64.75%	15,786 $782,000
Q3 2020 Nov 06, 2020	BUY	$35.13 - $43.62 $40,715 - $50,555	1,159 Added 13.76%	9,582 $368,000
Q2 2020 Aug 17, 2020	BUY	$23.66 - $49.53 $199,288 - $417,191	8,423 New	8,423 $364,000
Q2 2020 Aug 11, 2020	SELL	$23.66 - $49.53 $204,966 - $429,078	-8,663 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$14.39 - $35.8 $124,660 - $310,135	8,663 New	8,663 $226,000

22.4M

37.4K

48.2K

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $528M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.